UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO - 14 Jun 2024 Form 4 Insider Report for Aileron Therapeutics, Inc. (RNTX)

Role
10%+ Owner
Signature
/s/ Joan Moeller, Chief Operating Officer
Issuer symbol
RNTX
Transactions as of
14 Jun 2024
Net transactions value
-$21,568
Form type
4
Filing time
17 Jun 2024, 19:03:29 UTC
Previous filing
12 Jun 2024
Next filing
27 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALRN Common Stock Sale $6,270 -1,900 -0.11% $3.30 1,751,256 14 Jun 2024 Direct F1
transaction ALRN Common Stock Sale $15,298 -4,707 -0.27% $3.25 1,746,549 17 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.